Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000372

Director sold 8,000 shares at an average $509.98 ($4,079,823)

  • Director acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STEER RANDOLPH C · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-07 Exercise or conversion : show line 1 in the form +4,000 $87.39 $349,560 9,112 D
2021-09-07 Exercise or conversion : show line 2 in the form +4,000 $91.78 $367,120 13,112 D
2021-09-07 Sale : show line 3 in the form −2,900 $509.33 $1,477,046 10,212 D
2021-09-07 Sale : show line 4 in the form −4,600 $510.23 $2,347,052 5,612 D
2021-09-07 Sale : show line 5 in the form −500 $511.45 $255,725 5,112 D
Open-market sales · 8,000 sh · avg $509.98 · $4,079,823

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-09-07 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −4,000 0 D
2021-09-07 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −4,000 0 D
Loading xslF345X03/edgar.xml…